Location: Home
  • search
  • go
  • Relate News
  • 4/1/2025Akeso Eyes U.S. Approval for Innovative Lung Cancer Therapy
  • 3/28/2025Chinese Scientists Develop Breakthrough Vaccine Molecule to Enhance Im...
  • 3/27/2025Big Pharma Faces Headwinds in China as Vaccine Sales Decline (PT)
  • 3/25/2025Everest Announces FDA Clearance of IND Application for Tumor-Associate...
  • 3/24/2025GenScript's RA Drug Candidate Receives FDA Clearance for Clinical Tria...
  • 3/21/2025Dizal's Golidocitinib in Combo with Anti-PD-1 Shows Promise in IO Resi...
  • 3/21/2025Hengrui's Ivarmacitinib Secures First Approval in China for Ankylosing...
  • 3/21/2025Gilead's Trodelvy Receives Second Approval in China
  • 3/19/2025MSD Expands Public Health Efforts in China Following HPV Vaccine Appro...
  • 3/14/2025BioCity Announces Clinical Collaboration to Evaluate BC3195 in Combo w...
  • 3/12/2025Akeso Initiates Phase III Trial of Ivonescimab Plus Chemotherapy for m...
  • 3/11/2025Chinese Scientists Develop Potential Vaccine to Prevent Stroke and Hea...
  • 3/4/2025Insilico and Tenacia Announce Research Collaboration for CNS Drug Disc...
  • 2/28/2025NMPA Approves Multiple Drugs for Cancer, Cardiovascular, and Liver Dis...
  • 2/28/2025SciClone Secures Rights to Eisai's Tasurgratinib for Greater China
  • 2/25/2025Pfizer to Study China-Originated Ivonescimab in ADC Combo Under Summit...
  • 2/25/2025BioCity's SC0062 Achieves Primary Endpoint in Phase 2 DKD Trial
  • 2/21/2025NMPA Announces Package Insert Revision of Fluorouracil Injection
  • 2/20/2025Chimigen Secures CNY100M+ in Pre-A Financing to Advance Cancer and Hep...
  • 2/14/2025NMPA Approves SciClone's Vibativ for Drug-Resistant Gram-Positive Infe...
  • 2/14/2025China's Health Insurance Premiums Reached $134B in 2024, Up 8.2% YoY
  • 2/13/2025Jiangsu Recbio's Novel HPV Vaccine Trial Approved in China
  • 2/12/2025CSPC Granted NMPA Approval for Herpes Zoster mRNA Vaccine Clinical Tri...
  • 2/11/2025China's Digital Health Sector Poised for Growth Amid Data Security Con...
  • 2/7/2025NMPA Announces Package Insert Revision of Gemifloxacin Mesylate Tablet...
  • 2/6/2025GSK Faces Vaccine Challenges in China Amid Market Pressures
  • 2/6/2025Merck Halts HPV Vaccine Supply: What It Says about China Market (EGGI)
  • 2/5/2025Merck Faces Growing Challenges in China as Gardasil Sales Stall  
  • 1/28/2025Chinese Researchers Develop Promising Nanovaccine for Breast Cancer Tr...
  • 1/23/2025CDE Issues the Guidelines for Writing Clinical-Related Information in ...
  • Page:3/73 Total number of articles:2177: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group